FDA Approves New Immunotherapy Combo for Liver Cancer
Recommended
FDA Approves New Immunotherapy Combo for Liver Cancer
The US Food and Drug Administration (FDA) has approved a new immunotherapy combination for use in the treatment of unresectable heaptocellular carcinoma (HCC), the most common type of liver cancer.
<!-- BEGIN ADVERTSERVE CODE -->
<div id="mobile_block_ad_1"><script type="text/javascript">
var _avp = _avp || [];
_avp.push({ tagid: 'mobile_block_ad_1', alias: '/', type: 'banner', zid: 1669, pid: 0, onscroll: 0, inview: true, secure: true });
</script></div>
<!-- END ADVERTSERVE CODE -->